Title: Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors.
Journal: Journal of medicinal chemistry 20121227
Title: Biochemical characterization of TAK-593, a novel VEGFR/PDGFR inhibitor with a two-step slow binding mechanism.
Journal: Biochemistry 20110208
Title: Miyamoto N, et al. Discovery of N--({2-[(cyclopropylcarbonyl)aminoimidazo,2-bpyridazin-6-yl}oxy)-2-methylphenyl-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Bioorg Med Chem. 2013 Apr 15;21(8):2333-2345.
Title: Awazu Y, et al. Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase. Cancer Sci. 2013 Apr;104(4):486-94.
